BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34722283)

  • 1. Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report.
    Wang T; Huang Y; Huang X; Lv Z; Tian S; Ma X; Zhang X
    Front Oncol; 2021; 11():735077. PubMed ID: 34722283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.
    Iribe Y; Furuya M; Shibata Y; Yasui M; Funahashi M; Ota J; Iwashita H; Nagashima Y; Hasumi H; Hayashi N; Makiyama K; Kondo K; Tanaka R; Yao M; Nakaigawa N
    Fam Cancer; 2021 Jan; 20(1):75-80. PubMed ID: 32666341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
    Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI
    BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature.
    Yu Y; Zheng M; Zhu W; Zhao F; Guan B; Shen Q; Yang F; He Q; Li X
    Urol Oncol; 2021 Nov; 39(11):791.e9-791.e16. PubMed ID: 34462205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A CASE OF FUMARATE HYDRATASE (FH)-DEFICIENT RENAL CELL CARCINOMA SUSPECTED OF HEREDITARY LEIOMYOMATOSIS RENAL CELL CARCINOMA].
    Hagiwara K; Urakami S; Sakaguchi K; Nagamoto S; Hayashida M; Oka S; Ogawa K; Okaneya T; Fujii T; Nagashima Y; Furuya M
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(3):141-145. PubMed ID: 35858809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a tailored therapeutic approach.
    Wyvekens N; Valtcheva N; Mischo A; Helmchen B; Hermanns T; Choschzick M; Hötker AM; Rauch A; Mühleisen B; Akhoundova D; Weber A; Moch H; Rupp NJ
    Genes Chromosomes Cancer; 2020 Nov; 59(11):611-619. PubMed ID: 32537760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
    Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
    Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
    Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
    Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
    Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
    Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral fumarate hydratase deficient renal cell carcinoma in a patient with hereditary leiomyomatosis and renal cell cancer syndrome.
    Ono A; Nakamura M; Takada T; Miura S; Tsuru I; Izumi T; Kusakabe M; Mitarai S; Nagashima Y; Kume H; Morikawa T; Shiga Y
    IJU Case Rep; 2024 Mar; 7(2):144-147. PubMed ID: 38440695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary leiomyomatosis and renal cell carcinoma.
    Schmidt LS; Linehan WM
    Int J Nephrol Renovasc Dis; 2014; 7():253-60. PubMed ID: 25018647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
    Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
    Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
    Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR
    Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel case of hereditary leiomyomatosis- associated renal cell carcinoma with metastasis to pituitary gland.
    Palma CA; Watson G; Earls P; Patanjali N; Laurence J; Leslie S
    Urol Case Rep; 2022 Nov; 45():102206. PubMed ID: 36105545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
    Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
    Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
    Ooi A
    Semin Cancer Biol; 2020 Apr; 61():158-166. PubMed ID: 31689495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Non-Hereditary Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
    Kapila V; Kalra AG; Stockman DL
    Cureus; 2021 Feb; 13(2):e13344. PubMed ID: 33747650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fumarate hydratase as a therapeutic target in renal cancer.
    Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G
    Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC.
    Dai K; Jiang W; Chen S; Luo S; Ding S; Wang D
    Front Oncol; 2022; 12():932996. PubMed ID: 36330476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of hereditary leiomyomatosis and renal cell carcinoma (HLRCC).
    Nohara S; Nakanishi S; Matsuo T; Tamaki T; Saito S
    Urol Case Rep; 2024 May; 54():102738. PubMed ID: 38633512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.